Readership
Bioengineers, Biomedical Researchers, Chemists, Medicinal Chemists, Pharmacologists, Researchers, Scientists, Statisticians, Toxicologists
Scope
Reliable data obtained from selective, sensitive and reproducible analysis of xenobiotics and biotics in biological samples is a fundamental and crucial part of every successful drug development program. The same principles can also apply to many other areas of research such as forensic science, toxicology and sports doping testing.
The bioanalytical field incorporates sophisticated techniques linking sample preparation and advanced separations with MS and NMR detection systems, automation and robotics. Standards set by regulatory bodies regarding method development and validation increasingly define the boundaries between speed and quality.
Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing.
The journal Bioanalysis focuses on the techniques and methods used for the detection or quantitative study of analytes in human or animal biological samples. Bioanalysis encourages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimensional techniques.
Bioanalysis delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for the modern bioanalyst.
Principal themes include:
Analyte extraction and sample preparation, including microsampling, Chromatography and separation sciences, MS, NMR and other key detection methods, including ligand binding assays, Drug and metabolite assays, Biomarker assays, diagnostic assays and test kits, Method development and validation approaches, Innovative bioanalytical methods and new instrumentation and equipment, Laboratory automation and efficiency, Regulatory and compliance issues, Data processing and management.
The content is uniquely targeted to those working on the bioanalysis of drugs, metabolites and endogenous substances in biological matrices. This is, primarily, bioanalysts working in pharmaceutical research and development in industry and academia, clinical laboratories, clinical toxicologists, forensic toxicologists and sports doping analysts. The articles will also have wide appeal to analytical chemists, pharmacologists, clinical chemists, and those involved with metabolomics studies.